Fig. 3From: Radiation exposure of the spleen during 177Lu-DOTATATE treatment and its correlation with haematological toxicity and spleen volumeCorrelations between total absorbed spleen dose and relative decline in Hb count during 177Lu-DOTATATE treatment, for all patients (a) and for patients without bone metastases (b), and correlations between mean absorbed spleen dose per treatment and PLT count, for all patients (c) and for patients without bone metastases (d)Back to article page